New Guide To Musculoskeletal Ultrasound Teaches Diagnosticians And Technicians The Latest Techniques
Musculoskeletal Ultrasound of the Extremities by Dr. Randy E. Moore is a straight-forward, easy-to-follow guide which stresses recognition of normal anatomy as a prerequisite to identifying pathology. In the last 20 years, diagnostic ultrasonography has made tremendous strides.
Study Shows That Prostate Cancer Increases The Risk Of Bone Fracture
As unlikely as it sounds, scientists at the Garvan Institute for Medical Research have shown that there is a link between prostate cancer and a higher risk of bone fracture. Analysis of data from Garvan's Dubbo Osteoporosis Epidemiology Study suggests that men with prostate cancer face a 50% higher risk of fracture, which increases to nearly doubled risk if they are receiving treatment.
Physician-Dentist Collaboration Would Benefit Osteoporosis Treatment
Physicians and dentists should collaborate to improve early detection and treatment of patients who have or may develop osteoporosis, say researchers in the cover story of the May issue of The Journal of the American Dental Association.The authors of the article, "Osteoporosis and Its Implications for Dental Patients, " reviewed the medical and dental literature to examine osteoporosis' effect on public health in the United States.
IDM Pharma Announces Updated Data From Mifamurtide L-MTP-PE Compassionate Access Program
IDM Pharma, Inc. (the Company) (Nasdaq: IDMI) announced the presentation of updated data from a compassionate access program evaluating mifamurtide (L-MTP-PE) in patients with lung metastases as a result of the progression of osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults.
Orthopaedic Hospital Offers Low Cost Bone Density Screenings In Observance Of National Women's Health Week And May Osteoporosis Prevention Month
For most people, the month of May is synonymous with the time tested tradition of spring cleaning and organizing. As many people set aside time for spring activities, May also signifies National Women's Health Week (May 11 - 17) and Osteoporosis Prevention Month - two significant occasions that Orthopaedic Hospital supports with its offering of $50 bone density screenings to fight the growing prevalence of osteoporosis, a silent and widespread disease that causes more than 1.
New Data At ERA-EDTA Show Mimpara R Cinacalcet Improves Management Of Secondary Hyperparathyroidism In Daily Clinical Practice
Amgen (Europe) GmbH announced results from the Evaluation of the Clinical Use of Mimpara in Haemodialysis and Peritoneal Dialysis Patients, an Observational Study (ECHO) at the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) congress.
SUFE Slipped Upper Femoral Epiphysis - Delay In Diagnosing Can Be Devastating
Delayed diagnosis of slipped upper femoral epiphysis (SUFE) can result in lifelong disability and medicolegal claims of more than ^Alb100, 000, according to a report in the latest (Spring 2008) edition of Summons, the magazine of MDDUS, The Medical and Dental Defence Union of Scotland.
Depuy Spine Launches New Expedium TM Peek Rod System - Load Sharing Design, Imaging Compatibility, System Versatility
DePuy Spine, Inc., a Johnson & Johnson company, announced the launch of the EXPEDIUM™ PEEK Rod System, a load-sharing posterior instrumentation system designed to increase anterior column loading and support the interbody fusion process in the thoracolumbar spine.
Patients Treated For Chronic Tendinosis With TOPAZ R Highly Satisfied Study Shows
ArthroCare Corp. (Nasdaq: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced results from its five-year study evaluating the effectiveness of the TOPAZ MicroDebrider to treat common tendon disorders, and concluded patients who had the minimally invasive procedure were highly satisfied with the procedure and continue to experience pain relief.
Osteologix IND For NB S101 For Osteoporosis Accepted By FDA
Osteologix, Inc. (OLGX.OB), a specialty biopharmaceutical company, announced that the U. S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for its lead development candidate NB S101 (strontium malonate), for the treatment and prevention of osteoporosis.